A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants (clinicaltrials.gov) - May 16, 2026 - P1 | N=57 | Recruiting | Sponsor: Endeavor Biomedicines, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
|